Skip to main content
Premium Trial:

Request an Annual Quote

With Instrument Launch Nearing, Pacific Biosciences Creates Software Developers Network

Premium

This article was originally published July 12.

As it readies its first sequencing instruments for shipment to early-access customers, Pacific Biosciences said last week that it has launched a software developers network.

The network, called PacBio DevNet, serves to support academic informatics developers, life science researchers, and software vendors interested in creating tools that work with data from the PacBio RS sequencer.

The initiative complements PacBio's "strong internal focus on informatics development," and the company is "committed to supporting third-party software development and facilitating the rapid adoption of this new data type into the scientific community," according to chief scientific officer Eric Schadt.

"Single-molecule real-time sequencing introduces entirely new dimensions to data, such as a time component, that are unlike anything the bioinformatics community has encountered to this point," he said in a statement.

Network members, who can sign up on a website, will receive data sets, source code for algorithms, application programming interfaces, conversion tools to industry standard formats, and documentation related to single-molecule real-time sequencing.

PacBio has already been "working closely with members of the informatics community to develop and define standards for working with single-molecule sequence data," according to a company statement, but the new network is "a more formal program to support the needs of the informatics community."

The firm and its collaborators have so far developed new algorithms tailored to PacBio's data, as well as a suite of data management and analysis software tools that integrate with a user's LIMS system. These tools are available from PacBio under an open source license.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.